FY2025 EPS Estimates for SPRY Lowered by Cantor Fitzgerald
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Investment analysts at Cantor Fitzgerald dropped their FY2025 earnings per share estimates for shares of ARS Pharmaceuticals in a research report issued to clients and investors on Monday, March 24th. Cantor Fitzgerald analyst J. Schimmer now anticipates that the company will post earnings per share of ($1.21) […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Investment analysts at Cantor Fitzgerald dropped their FY2025 earnings per share estimates for shares of ARS Pharmaceuticals in a research report issued to clients and investors on Monday, March 24th. Cantor Fitzgerald analyst J. Schimmer now anticipates that the company will post earnings per share of ($1.21) […]
